Valuation: Protia Inc.

Market Cap 69.16B 51.35M 44.49M 41.99M 38.09M 71.46M 4.92B 71.97M 501M 193M 2.5B 193M 189M 7.94B P/E 2024
14.5x
P/E 2025 18x
Enterprise Value 55.78B 41.41M 35.89M 33.87M 30.72M 57.63M 3.97B 58.05M 404M 156M 2.01B 156M 152M 6.4B EV / Sales 2024
2.1x
EV / Sales 2025 4.43x
Free-Float
57.15%
Yield 2024 *
-
Yield 2025 -
1 day+2.29%
1 week+6.34%
Current month+0.56%
1 month+9.15%
3 months+28.62%
6 months+8.59%
Current year-13.94%
1 week 5,020
Extreme 5020
5,510
1 month 4,650
Extreme 4650
5,510
Current year 3,680
Extreme 3680
6,240
1 year 3,680
Extreme 3680
6,890
3 years 2,430
Extreme 2430
6,890
5 years 2,430
Extreme 2430
8,440
10 years 2,430
Extreme 2430
17,350
Manager TitleAgeSince
Chief Executive Officer 65 2010-05-31
Corporate Officer/Principal 61 2022-06-02
Sales & Marketing 69 -
Director TitleAgeSince
Director/Board Member 65 2010-05-31
Director/Board Member 61 2022-06-02
Director/Board Member 68 2020-10-23
Change 5-day change 1-year change 3-year change Capi.($)
+2.29%+6.34%-7.57%+50.00% 50.44M
+6.65%+3.98%+205.75%+445.64% 21.12B
+1.63%-1.38%-37.84%-22.77% 9.62B
+2.22%+11.91%+454.67%+41.66% 8.94B
+7.03%+3.91%-23.52% - 6.88B
+0.07%-0.64%+89.50%+51.18% 6.54B
+0.75%-4.69%-28.99%-22.57% 5.64B
+0.68%-0.19%-6.62%-20.11% 4.22B
-3.58%-14.94%+50.90%+61.40% 3.84B
+1.89%-2.40%-22.85%-30.45% 2.65B
Average +1.96%-0.04%+67.34%+61.55% 6.95B
Weighted average by Cap. +3.21%-0.18%+121.03%+157.23%

Financials

2024 2025
Net sales 10.51B 7.81M 6.76M 6.38M 5.79M 10.86M 748M 10.94M 76.23M 29.38M 380M 29.32M 28.67M 1.21B 15.12B 11.23M 9.73M 9.18M 8.33M 15.62M 1.08B 15.73M 110M 42.24M 546M 42.16M 41.23M 1.74B
Net income 2.44B 1.81M 1.57M 1.48M 1.34M 2.52M 174M 2.54M 17.71M 6.82M 88.15M 6.81M 6.66M 280M 4.47B 3.32M 2.88M 2.71M 2.46M 4.62M 318M 4.65M 32.42M 12.49M 161M 12.47M 12.19M 513M
Net Debt -13.23B -9.83M -8.51M -8.03M -7.29M -13.67M -942M -13.77M -95.96M -36.98M -478M -36.9M -36.09M -1.52B -13.38B -9.93M -8.61M -8.12M -7.37M -13.82M -952M -13.92M -97.01M -37.38M -483M -37.31M -36.49M -1.54B
Logo Protia Inc.
Protia Inc is a Korea-based company mainly engaged in the research and development of in vitro diagnostic medical devices and diagnostic reagents. The Company mainly produces allergy diagnostic reagents, allergy diagnostic equipment, point-of-care diagnosis products (POCT), among others. In addition, the Company is engaged in provision of protein related analysis services.
Employees
-
Date Price Change Volume
26-09-14 ₩5,370.00 +2.29% 42,065
26-09-11 ₩5,250.00 +1.35% 16,121
26-09-10 ₩5,180.00 +0.19% 43,430
26-09-09 ₩5,170.00 +2.99% 13,738
26-09-08 ₩5,020.00 -0.59% 14,212
  1. Stock Market
  2. Stocks
  3. A303360 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!